In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Diclofenac, Sodium Drug Master File in Korea (Diclofenac, Sodium KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Diclofenac, Sodium. The MFDS reviews the Diclofenac, Sodium KDMF as part of the drug registration process and uses the information provided in the Diclofenac, Sodium KDMF to evaluate the safety and efficacy of the drug.
After submitting a Diclofenac, Sodium KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Diclofenac, Sodium API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Diclofenac, Sodium suppliers with KDMF on PharmaCompass.